Dr. Ge is a member of the Boston Patent Law Association and the American Intellectual Property Law Association. She is the first author of numerous peer-reviewed articles in journals, including Genes & Development, The Journal of Cell Biology and Genome Biology. She presented her research frequently at national and international conferences.
Prior to joining Goodwin, Dr. Ge interned at the Yale University Technology Transfer Office, where she examined issues of commercialization and patentability related to life sciences inventions. Earlier, Dr. Ge did postdoctoral research at the Yale Stem Cell Center, where she was the principle investigator of a grant and studied mechanisms of embryonic stem cells to maintain genomic stability during self-renewal and differentiation. Dr. Ge earned her doctoral degree at the University of Dundee, UK, where she discovered a novel mechanism to protect cells from DNA damage during chromosome replication and to prevent tumorigenesis. Dr. Ge also worked at Eli Lilly & Company, where she performed drug target validation using cell-based and biochemical pharmacological assays.